Stay updated with breaking news from Planned Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Beauty Health Company (NASDAQ:SKIN) Q4 2023 Earnings Call Transcript March 12, 2024 The Beauty Health Company beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.11. The Beauty Health Company isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Meeting Provided a Clear Path for Planned Phase 3b Trial NEW YORK, Dec. 7, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for...
Submitted a new drug application (NDA) for troriluzole in Spinocerebellar Ataxia Type 3 (SCA3) to U.S. FDA in 2Q2023, marking the team's fourth NDA in...
Plus Therapeutics Provides Updates on ReSPECT™ Clinical Trials at the 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology - read this article along with other careers information, tips and advice on BioSpace
ReSPECT-GBM clinical trial of rhenium (186Re) obisbemeda in recurrent glioblastoma continues to demonstrate safety and overall survival correlates with...